PT - JOURNAL ARTICLE AU - Dolbeault, Jean AU - Turinici, Gabriel TI - Social heterogeneity and the COVID-19 lockdown in a multi-group SEIR model AID - 10.1101/2020.05.15.20103010 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.15.20103010 4099 - http://medrxiv.org/content/early/2020/05/20/2020.05.15.20103010.short 4100 - http://medrxiv.org/content/early/2020/05/20/2020.05.15.20103010.full AB - The goal of the lockdown is to mitigate and if possible prevent the spread of an epidemic. It consists in reducing social interactions. This is taken into account by the introduction of a factor of reduction of social interactions q, and by decreasing the transmission coefficient of the disease accordingly. Evaluating q is a difficult question and one can ask if it makes sense to compute an average coe cient q for a given population, in order to make predictions on the basic reproduction rate ℛ0, the dynamics of the epidemic or the fraction of the population that will have been infected by the end of the epidemic. On a very simple example, we show that the computation of ℛ0 in a heterogeneous population is not reduced to the computation of an average q but rather to the direct computation of an average coe cient ℛ0. Even more interesting is the fact that, in a range of data compatible with the Covid–19 outbreak, the size of the epidemic is deeply modified by social heterogeneity, as is the height of the epidemic peak, while the date at which it is reached mainly depends on the average ℛ0 coefficient. This short note is an application and a summary of the technical results that can be found in [4].Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has been partially supported by the Project EFI (ANR-17-CE40-0030) of the French National Research Agency (ANR). The authors thank the CNRS-MODCOV19 platform for support.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo private data has been used in this work.